- The kinetochore is a large, multi‑protein structure assembled on centromeric chromatin and serves as the essential interface between chromosomes and spindle microtubules during mitosis. It is responsible for capturing spindle microtubules, generating the forces required for chromosome movement and transmitting mechanical tension that signals correct bi‑orientation. Because accurate chromosome segregation depends entirely on the fidelity of kinetochore–microtubule interactions, the kinetochore is one of the most critical structures in cell division.
- Structurally, the kinetochore is divided into two major regions: the inner kinetochore, which is embedded in centromeric chromatin, and the outer kinetochore, which directly interacts with spindle microtubules. The inner kinetochore is built upon CENP‑A–containing nucleosomes, which define centromere identity and provide a foundation for the constitutive centromere‑associated network (CCAN). This network maintains centromere structure throughout the cell cycle. The outer kinetochore is assembled only during mitosis and contains the KMN network, composed of the KNL1 complex, the Mis12 complex and the Ndc80 complex. These proteins form the core microtubule‑binding interface and generate the attachments required for chromosome movement.
- The kinetochore is not a static structure; it is highly dynamic and continuously remodelled as microtubules attach, detach and generate tension. During early mitosis, kinetochores frequently form incorrect attachments because microtubules capture them through a random search‑and‑capture mechanism. These erroneous attachments are corrected through the action of Aurora B kinase and the Chromosomal Passenger Complex. Aurora B phosphorylates outer‑kinetochore substrates such as Ndc80, KNL1 and Dsn1, weakening microtubule binding and destabilising faulty attachments. As tension increases across bi‑oriented sister kinetochores, Aurora B becomes spatially separated from its substrates, allowing stable attachments to form.
- The kinetochore also plays a central role in the spindle assembly checkpoint. Unattached or tension‑free kinetochores recruit checkpoint proteins including Mad1, Mad2, Bub1, BubR1 and Mps1. These proteins generate a diffusible inhibitory signal that prevents activation of the anaphase‑promoting complex/cyclosome (APC/C), thereby blocking sister chromatid separation. Once all kinetochores achieve proper attachment and tension, checkpoint proteins dissociate, allowing APC/C activation and anaphase onset. In this way, the kinetochore acts as both a mechanical sensor and a biochemical signalling hub.
- Beyond attachment and checkpoint signalling, kinetochores generate the forces required for chromosome movement. They harness microtubule dynamics—particularly depolymerisation at microtubule plus ends—to pull chromosomes toward spindle poles. Motor proteins such as dynein and kinesins also contribute to kinetochore motility, ensuring coordinated chromosome alignment at metaphase and separation during anaphase.
- Kinetochore dysfunction has profound consequences for genomic stability. Defects in kinetochore assembly, microtubule binding or checkpoint signalling lead to chromosome mis‑segregation, aneuploidy and chromosomal instability (CIN). These abnormalities are hallmarks of many cancers, where altered kinetochore composition, weakened checkpoint signalling and mis‑regulated Aurora B activity allow tumour cells to divide despite persistent segregation errors. Because of its central role in mitosis, the kinetochore is a major target of anti‑mitotic therapies, including microtubule‑targeting agents that disrupt kinetochore–microtubule attachment and induce prolonged checkpoint activation.
- In summary, the kinetochore is a dynamic, tension‑sensing, microtubule‑binding structure that ensures accurate chromosome segregation. By coordinating microtubule attachment, force generation, error correction and checkpoint signalling, it preserves genomic stability and prevents aneuploidy. Its dysfunction contributes to cancer progression, making it a focal point of mitotic research and therapeutic development.
